3 insiders reported 6 Form 4 transactions for Pyxis Oncology, Inc. (PYXS) over the past 18 months (most recent 2026-07-02). Recent activity: Dupont Jakob (Director) Buy 35,000 shares, Dupont Jakob (Director) Sell 35,000 shares, Wadhane Jitendra (Prin Fin & Acct Officer) Buy 109,461 shares, HUMPHREY RACHEL (Director) Sell 1,400 shares, HUMPHREY RACHEL (Director) Sell 200 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Dupont Jakob | Director | Buy | 35,000 | $56,000 |
| 2026-07-02 | Dupont Jakob | Director | Sell | 35,000 | $107,100 |
| 2026-03-25 | Wadhane Jitendra | Prin Fin & Acct Officer | Buy | 109,461 | $0 |
| 2026-03-25 | HUMPHREY RACHEL | Director | Sell | 1,400 | $1,358 |
| 2026-03-25 | HUMPHREY RACHEL | Director | Sell | 200 | $194 |
| 2026-03-25 | HUMPHREY RACHEL | Director | Sell | 13,896 | $14,313 |
Source: SEC Form 4 filings · as of 2026-07-02